Proven cholesterol lowering effect
In a randomized, double-blind, double-dummy, active-controlled clinical trial with 232 volunteers aged 25 to 60 years with stage 1 hypertension (systolic blood pressure 140-159 mmHg, and/or diastolic blood pressure 90-99 mmHg) showed not only a blood pressure reduction but also a significant reduction of total cholesterol and triglycerides levels which was not observed in the anti-hypertensive drug Captopril group.
These findings echo the results of a preliminary study in twins, conducted in Germany which demonstrated a significant dose-dependent reduction of LDL (Low Density Lipoprotein) cholesterol for 500 mg and 1000 mg per day of Benolea® after 8 weeks. Increased levels of LDL are associated with atherosclerosis, and thus heart attack, stroke and peripheral vascular disease. For this reason, LDL cholesterol is often called ‘bad’ cholesterol.